|
|
|
|
Vol. 56, Issue 4, 720-727, October 1999
Department of Pharmacological and Physiological Sciences, St. Louis
University School of Medicine, St. Louis, Missouri
We recently reported that a novel hetero-oligomeric P2X receptor is
formed from the P2X1 and P2X5 isoforms when
coexpressed in human embryonic kidney 293 cells (Torres et al., 1998).
A more complete description of the pharmacology of this novel receptor is presented here. A brief application of ATP to a voltage-clamped cell
transiently expressing P2X1/5 receptors resulted in a
biphasic current that rapidly reached a peak and then decayed to a
sustained plateau. Washout of ATP was accompanied by generation and
fade of a pronounced tail of inward current. EC50 values
were determined from concentration-response curves for a range of
agonists. The rank order of agonist potency was ATP
2 methylthio ATP > adenosine 5'-O-(3-thiotriphosphate) >
,
-methylene ATP > ADP > CTP.
,
-methylene ADP, UTP, GTP, and AMP were
ineffective. Only ATP and 2 methylthio ATP were full agonists.
IC50 values were determined from concentration-response curves for three commonly used purinergic antagonists. Suramin and
pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid
were equipotent at P2X1 and P2X1/5 receptors;
however, the P2X1/5 receptor was much less sensitive to
TNP-ATP than was the P2X1 receptor. The amplitude of peak
ATP-gated current was relatively insensitive to changes in
[Ca2+]O (1-30 mM). Finally, plateau currents
were potentiated by low concentrations of pyridoxal
phosphate-6-azophenyl-2', 4'-disulfonic acid and by
raising [Ca2+]O. These results provide
additional information on the pharmacological profile of the
recombinant P2X1/5 receptor channel and provide a basis to
further evaluate ATP-induced currents in native tissues.
This article has been cited by other articles:
![]() |
U. Lalo, Y. Pankratov, S. P. Wichert, M. J. Rossner, R. A. North, F. Kirchhoff, and A. Verkhratsky P2X1 and P2X5 Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes J. Neurosci., May 21, 2008; 28(21): 5473 - 5480. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fabbretti, E. Sokolova, L. Masten, M. D'Arco, A. Fabbro, A. Nistri, and R. Giniatullin Identification of Negative Residues in the P2X3 ATP Receptor Ectodomain as Structural Determinants for Desensitization and the Ca2+-sensing Modulatory Sites J. Biol. Chem., December 17, 2004; 279(51): 53109 - 53115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuzuki, A. Ase, P. Seguela, T. Nakatsuka, C.-Y. Wang, J.-X. She, and J. G. Gu TNP-ATP-Resistant P2X Ionic Current on the Central Terminals and Somata of Rat Primary Sensory Neurons J Neurophysiol, June 1, 2003; 89(6): 3235 - 3242. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakatsuka, K. Tsuzuki, J. X. Ling, H. Sonobe, and J. G. Gu Distinct Roles of P2X Receptors in Modulating Glutamate Release at Different Primary Sensory Synapses in Rat Spinal Cord J Neurophysiol, June 1, 2003; 89(6): 3243 - 3252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wildman, S. G. Brown, M. Rahman, C. A. Noel, L. Churchill, G. Burnstock, R. J. Unwin, and B. F. King Sensitization by Extracellular Ca2+ of Rat P2X5 Receptor and Its Pharmacological Properties Compared with Rat P2X1. Mol. Pharmacol., October 1, 2002; 62(4): 957 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. North Molecular Physiology of P2X Receptors Physiol Rev, October 1, 2002; 82(4): 1013 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cinkilic, B. F. King, M. van der Giet, H. Schluter, W. Zidek, and G. Burnstock Selective Agonism of Group I P2X Receptors by Dinucleotides Dependent on a Single Adenine Moiety J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 131 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakatsuka and J. G. Gu ATP P2X Receptor-Mediated Enhancement of Glutamate Release and Evoked EPSCs in Dorsal Horn Neurons of the Rat Spinal Cord J. Neurosci., September 1, 2001; 21(17): 6522 - 6531. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, B. F. King, P. M. Dunn, W. Rong, A. Townsend-Nicholson, and G. Burnstock Coexpression of P2X3 and P2X2 Receptor Subunits in Varying Amounts Generates Heterogeneous Populations of P2X Receptors That Evoke a Spectrum of Agonist Responses Comparable to That Seen in Sensory Neurons J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 1043 - 1050. [Abstract] [Full Text] |
||||
![]() |
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. King, A. Townsend-Nicholson, S. S. Wildman, T. Thomas, K. M. Spyer, and G. Burnstock Coexpression of Rat P2X2 and P2X6 Subunits in Xenopus Oocytes J. Neurosci., July 1, 2000; 20(13): 4871 - 4877. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Haines, K. Migita, J. A. Cox, T. M. Egan, and M. M. Voigt The First Transmembrane Domain of the P2X Receptor Subunit Participates in the Agonist-induced Gating of the Channel J. Biol. Chem., August 24, 2001; 276(35): 32793 - 32798. [Abstract] [Full Text] [PDF] |
||||